Weber C, Stoeckel K, Lalka D
Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo 14222.
Pharm Res. 1994 Mar;11(3):420-5. doi: 10.1023/a:1018921306200.
(+)-Propranolol was infused at two rates into the pyloric vein (a portal vein tributary) of 15 male Sprague Dawley rats until apparent steady-state conditions were established (i.e., 8 hr at each rate). One group (n = 7) received the high dose (40 micrograms/min/kg) first, and in the other group (n = 8) the low dose (20 micrograms/kg/min) was used to initiate treatment. Free and total serum concentrations of propranolol were measured. When the low dose was given first, the apparent steady-state concentrations achieved during low- and high-rate infusion steps were 166 +/- 37 and 774 +/- 235 ng/mL, respectively. These data are consistent with a simple Michaelis-Menten kinetic model and the key parameters of such a model (Vmax and Km) were estimated. However, a crucial test of such a model (and one which should give insight regarding the relevance of an "altered enzyme hypothesis") is to reverse the order of infusion steps since, in a system controlled by Michaelis-Menten kinetics, the same steady-state concentrations should be achieved regardless of the order in which infusion steps are given. When the sequence of infusion rates was reversed, steady-state concentrations were 492 +/- 142 and 298 +/- 79 ng/mL for the high and low infusion rates, respectively. Clearly, a history of high-dose exposure reduces the intrinsic clearance of total drug (CLss) during a subsequent low-dose exposure (i.e., the apparent steady-state levels during the low-dose pyloric vein infusions were significantly different; P < 0.001). When these data were corrected for plasma protein binding, the same trends emerged.(ABSTRACT TRUNCATED AT 250 WORDS)
将(+)-普萘洛尔以两种速率输注到15只雄性斯普拉格-道利大鼠的幽门静脉(门静脉分支)中,直至建立明显的稳态条件(即每种速率下持续8小时)。一组(n = 7)先接受高剂量(40微克/分钟/千克),另一组(n = 8)先使用低剂量(20微克/千克/分钟)开始治疗。测量了普萘洛尔的游离和总血清浓度。当先给予低剂量时,低速率和高速率输注阶段达到的表观稳态浓度分别为166±37和774±235纳克/毫升。这些数据与简单的米氏动力学模型一致,并估算了该模型的关键参数(Vmax和Km)。然而,对该模型的一个关键测试(也是一个能洞察“酶改变假说”相关性的测试)是颠倒输注步骤的顺序,因为在由米氏动力学控制的系统中,无论输注步骤的顺序如何,都应达到相同的稳态浓度。当颠倒输注速率顺序时,高速率和低速率输注的稳态浓度分别为492±142和298±79纳克/毫升。显然,高剂量暴露史会降低随后低剂量暴露期间总药物的内在清除率(CLss)(即低剂量幽门静脉输注期间的表观稳态水平有显著差异;P < 0.001)。当对这些数据进行血浆蛋白结合校正时,出现了相同的趋势。(摘要截断于250字)